UPDATE: Wedbush Upgrades United Therapeutics (UTHR) to Outperform, Raises Fair Value Estimate to $94
Tweet Send to a Friend
Wedbush upgraded shares of United Therapeutics (Nasdaq: UTHR) from Neutral to Outperform Thursday following first-quarter earnings from the company earlier.
This article: 124 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This article: 124 words
-->
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
